ClinConnect ClinConnect Logo
Search / Trial NCT04513977

Geriatric Oncology SuPportive Clinic for ELderly

Launched by GOH WEN YANG · Aug 13, 2020

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

Geriatric Oncology Frailty Comprehensive Geriatric Assessment Quality Of Life

ClinConnect Summary

This clinical trial, called the Geriatric Oncology Supportive Clinic for Elderly (GOSC), is studying how a special supportive care program can improve the quality of life for older adults who have recently been diagnosed with cancer and are about to start treatment. The program aims to help these patients manage the challenges of cancer treatment, particularly focusing on their overall well-being.

To be eligible for this trial, participants must be 65 years or older, have a new diagnosis of early or locally advanced cancer, and be planning to receive treatment such as high-dose radiotherapy or chemotherapy. However, if someone has already been seen in a Geriatric or Palliative Medicine Clinic in the last six months, they won't be able to join. Those who participate can expect to receive tailored support and care, which may help them have a better experience during their cancer treatment. The trial is currently recruiting participants, and it welcomes people of all genders.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 65 and above
  • Newly diagnosed early or locally advanced cancer
  • Planned for treatment
  • high dose radiotherapy (both curative and palliative) and / or
  • curative chemotherapy
  • Exclusion Criteria:
  • Seen in Geriatric or Palliative Medicine Clinic in prior 6 months

About Goh Wen Yang

Goh Wen Yang is a dedicated clinical trial sponsor committed to advancing medical research and innovation. With a focus on enhancing patient outcomes and developing groundbreaking therapies, the organization collaborates with healthcare professionals and research institutions to design and implement rigorous clinical trials. Goh Wen Yang emphasizes ethical practices, regulatory compliance, and patient safety, ensuring that all studies are conducted with the highest standards of scientific integrity. Through its efforts, the organization aims to contribute significantly to the global understanding of diseases and the development of effective treatments.

Locations

Singapore, , Singapore

Patients applied

0 patients applied

Trial Officials

Wen Yang Goh

Principal Investigator

TTSH

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials